Unity Biotechnology, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 50 rows, 50 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-05-07: Reporting owner NELSEN ROBERT; Form 4; Security Series A-1 Preferred Stock; Transaction C Conversion of derivative security.
- 2018-05-07: Reporting owner NELSEN ROBERT; Form 4; Security Series A-2 Preferred Stock; Transaction C Conversion of derivative security.
- 2018-05-07: Reporting owner NELSEN ROBERT; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2018-05-07: Reporting owner NELSEN ROBERT; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-05-07 | NELSEN ROBERT Director, 10% Owner | 4 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,030,625 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | NELSEN ROBERT Director, 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,228,432 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | NELSEN ROBERT Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,067,160 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | NELSEN ROBERT Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,486,745 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | NELSEN ROBERT Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −195,672 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Goeltz II Robert C. Officer (Chief Financial Officer) | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,630 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BERNS PAUL L Director | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −3,261 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | David Nathaniel E Director, Officer (President) | 4 | Series A-2 Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,074,032 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | David Nathaniel E Director, Officer (President) | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −222,148 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | David Nathaniel E Director, Officer (President) | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,630 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Burow Kristina Director | 4 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,030,625 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Burow Kristina Director | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,228,432 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Burow Kristina Director | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,067,160 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Burow Kristina Director | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,486,745 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Burow Kristina Director | 4 | Series C Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −195,672 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Leonard Keith R Director, Officer (Chief Executive Officer) | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −383,475 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Leonard Keith R Director, Officer (Chief Executive Officer) | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −148,448 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Leonard Keith R Director, Officer (Chief Executive Officer) | 4 | Series C Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −1,630 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Dananberg Jamie Officer (Chief Medical Officer) | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −74,048 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | Dananberg Jamie Officer (Chief Medical Officer) | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,630 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BYBEE CLINTON | ARCH Venture Fund VII, L.P. | ARCH Venture Partners VIII, LLC | ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Partners VII, L.P. | ARCH Venture Partners VII, LLC | CRANDELL KEITH 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,030,625 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BYBEE CLINTON | ARCH Venture Fund VII, L.P. | ARCH Venture Partners VIII, LLC | ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Partners VII, L.P. | ARCH Venture Partners VII, LLC | CRANDELL KEITH 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,228,432 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BYBEE CLINTON | ARCH Venture Fund VII, L.P. | ARCH Venture Partners VIII, LLC | ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Partners VII, L.P. | ARCH Venture Partners VII, LLC | CRANDELL KEITH 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,067,160 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BYBEE CLINTON | ARCH Venture Fund VII, L.P. | ARCH Venture Partners VIII, LLC | ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Partners VII, L.P. | ARCH Venture Partners VII, LLC | CRANDELL KEITH 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,486,745 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-07 | BYBEE CLINTON | ARCH Venture Fund VII, L.P. | ARCH Venture Partners VIII, LLC | ARCH Venture Fund VIII Overage, L.P. | ARCH Venture Partners VII, L.P. | ARCH Venture Partners VII, LLC | CRANDELL KEITH 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −195,672 0 owned after | no price filed | 2018-05-07 | |
| 2018-05-03 holding as of filing | ARCH Venture Fund VIII Overage, L.P. | BYBEE CLINTON | ARCH Venture Partners VII, L.P. | Arch Venture Fund VII LP | ARCH Venture Partners VII, LLC | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director | 3 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-03 | ||
| 2018-05-03 holding as of filing | ARCH Venture Fund VIII Overage, L.P. | BYBEE CLINTON | ARCH Venture Partners VII, L.P. | Arch Venture Fund VII LP | ARCH Venture Partners VII, LLC | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-03 | ||
| 2018-05-03 holding as of filing | ARCH Venture Fund VIII Overage, L.P. | BYBEE CLINTON | ARCH Venture Partners VII, L.P. | Arch Venture Fund VII LP | ARCH Venture Partners VII, LLC | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-03 | ||
| 2018-05-03 holding as of filing | ARCH Venture Fund VIII Overage, L.P. | BYBEE CLINTON | ARCH Venture Partners VII, L.P. | Arch Venture Fund VII LP | ARCH Venture Partners VII, LLC | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-03 | ||
| 2018-05-03 holding as of filing | ARCH Venture Fund VIII Overage, L.P. | BYBEE CLINTON | ARCH Venture Partners VII, L.P. | Arch Venture Fund VII LP | ARCH Venture Partners VII, LLC | ARCH Venture Partners VIII, LLC | CRANDELL KEITH | NELSEN ROBERT 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director | 3 | Series C Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-03 | ||
| 2018-05-02 holding as of filing | Leonard Keith R Director, Officer (Chief Executive Officer) | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Leonard Keith R Director, Officer (Chief Executive Officer) | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Leonard Keith R Director, Officer (Chief Executive Officer) | 3 | Series C Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | NELSEN ROBERT Director, 10% Owner | 3 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | NELSEN ROBERT Director, 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | NELSEN ROBERT Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | NELSEN ROBERT Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | NELSEN ROBERT Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Burow Kristina Director | 3 | Series A-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Burow Kristina Director | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Burow Kristina Director | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Burow Kristina Director | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Burow Kristina Director | 3 | Series C Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Goeltz II Robert C. Officer (Chief Financial Officer) | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | BERNS PAUL L Director | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series A-2 Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | David Nathaniel E Director, Officer (President) | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Dananberg Jamie Officer (Chief Medical Officer) | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 | ||
| 2018-05-02 holding as of filing | Dananberg Jamie Officer (Chief Medical Officer) | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2018-05-02 |